Clinical Neuroscience

[Multiple tunnel syndromes at the wrist]

DALOS Márta1, MÁTÉ András1, KÓMÁR József1

AUGUST 01, 1985

Clinical Neuroscience - 1985;38(08)

[The authors report on 15 patients with double or multiple tunnel syndrome at the wrist (carpal, thenar and Guyon tunnel syndrome). They draw attention to the importance of electrophysiological investigations and the suspicion of thenar tunnel syndrome. They stress that in carpal tunnel syndrome surgery, the nerve should be followed until it enters the muscle. ]

AFFILIATIONS

  1. Újpesti Kórház-Rendelőintézet, Városi Kórház Organikus Ideggyógyászat

COMMENTS

0 comments

Further articles in this publication

Clinical Neuroscience

[Some problems in genetic counselling in schizophrenic psychoses]

CZEIZEL Endre, UNGVÁRI Gábor

[Authors summarize the key principles of diagnosis, genetics and genetic counselling of schizophrenic psychosis for practicing psychiatrists and the medical geneticist from the perspective of genetic counselling. With regard to the strategy of genetic counseling, the importance and simultaneous consideration of socio-cultural, socio-psychological factors and the family emotional-atmosphere are emphasized, in addition to nosological aspects. The special situation of schizophrenic (and psychiatric) patients and their families makes it advisable to set up a separate psychiatric genetic counselor. ]

Clinical Neuroscience

[Clinical genetic aspects of neurocutaneous diseases - tuberous sclerosis and neurofibromatosis, HLA-antigen testing and computed tomography diagnosis]

LÁSZLÓ Aranka, BARTHA László, CSOBÁLY Sándor, KAISER Gabriella, SVÉKUS András

[The authors performed HLA typing in 5 families with tuberous sclerosis (ST), demonstrating a significantly higher prevalence of HLA-A w31 antigen, without involvement of the B an antigen group. An autosomal dominant origin was confirmed in 4 families and a first gene mutation origin in 1 family, based on UV light examination of the outer skin of the family members, with detectable fluorescence of depigmented spots. Of 6 cases of neurofibromatosis (Nf), 4 were forme fruste forms, the inheritance pattern was autosomal dominant in 4 families and first gene mutation in 1 family was proven. The authors also discuss the diagnostic value of computed tomography in the above pathologies. ]

Clinical Neuroscience

[Treatment of paranoid psychotics combined with group discussions in care]

KAPPÉTER István, BOROS Magdolna

[For more than three years in a psychiatric unit, they have managed to engage 6 of the 36 paranoid psychotics referred to them for an hour a week, who need extra help. At his request, 2 sensitive neurotics with neurotic neuroses were linked to the group. The group, which had been operating under the same conditions as before, was characterised by the emotional and experiential involvement of the therapists, treating the patients as equals and observing the group process passively and impartially. The results of such complementary treatment are good, although miracles are not expected. As a new finding compared to the scarce literature worldwide on outpatient group psychotherapy with psychotics, we found that disengagement in such groups is difficult and requires even greater empathy and more developed self-awareness of the therapists than the group design. ]

Clinical Neuroscience

[Myasthenic myasthenia gravis: Total muscle lactic acid dehydrogenase (LDH) activity and LDH isoenzyme distribution]

SZATHMÁRY István, SELMECI László, PÓSCH Elek, SZOBOR Albert, MOLNÁR János

[The authors determined the total activity of lactic dehydrogenase (LDH) and malic dehydrogenase (MDH) per wet weight and the percentage distribution of LDH isoenzymes in muscle samples taken during thymectomy from the sternothyroid muscle of 62 patients with myasthenia gravis, and calculated the MDH/LDH ratio and the percentage of H and M subunits. In comparing their results with clinical data, they found that significant decreases in the percentage of LDH; isoenzyme and M subunit, and trend-like decreases in total LDH activity and increases in the MDH/LDH ratio per case, correlated with the degree of histopathologically detected ischemia in the samples and the frequency of clinically manifest ischemia and respiratory crises in the history. In their opinion, the biochemical abnormalities observed in the damaged muscle samples indicate a decrease in anaerobic glycolysis in the form of myasthenia gravis with myasthenia gravis associated with muscle atrophy. The histological examination revealed similar but milder abnormalities in intact muscle samples, in addition to an early biochemical sign of muscle destruction, raising the possibility of a possible biochemical level adaptive compensatory mechanism in myasthenic muscle. This study may be a useful adjunct to other known methods for the early detection of muscle wasting as a complication of myasthenia gravis. ]

Clinical Neuroscience

[Traumatic aneurysm in the cortical branch of the middle cerebral artery]

KÖVÉR Ferenc, MÉREI F. Tibor, GELLÉT Marianna

[The course of a female patient with a traumatic aneurysm of the cortical branch of the cerebral medial artery two months after a covered skull injury with a lineal fracture of the lamina vitrea is described. It highlights the importance of performing angiography in cases where the cause of deterioration following trauma is not detected by CT scanning. It provides data to identify the morphological features of traumatic intracranial aneurysms by histological processing of the aneurysm. ]

All articles in the issue

Related contents

Clinical Neuroscience

[Tension type headache and its treatment possibilities]

ERTSEY Csaba, MAGYAR Máté, GYÜRE Tamás, BALOGH Eszter, BOZSIK György

[Tension type headache, the most common type of primary headaches, affects approximately 80% of the population. Mainly because of its high prevalence, the socio-economic consequences of tension type headache are significant. The pain in tension type headache is usually bilateral, mild to moderate, is of a pressing or tightening quality, and is not accompanied by other symptoms. Patients with frequent or daily occurrence of tension type headache may experience significant distress because of the condition. The two main therapeutic avenues of tension type headache are acute and prophylactic treatment. Simple or combined analgesics are the mainstay of acute treatment. Prophylactic treatment is needed in case of attacks that are frequent and/or difficult to treat. The first drugs of choice as preventatives of tension type headache are tricyclic antidepressants, with a special focus on amitriptyline, the efficacy of which having been documented in multiple double-blind, placebo-controlled studies. Among other antidepressants, the efficacy of mirtazapine and venlafaxine has been documented. There is weaker evidence about the efficacy of gabapentine, topiramate, and tizanidin. Non-pharmacological prophylactic methods of tension type headache with a documented efficacy include certain types of psychotherapy and acupuncture. ]

Clinical Neuroscience

[Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus]

BERECZKI Dániel, STANG Rita, BÖJTI Péter, KOVÁCS Tibor

[By the spring of 2020 the COVID-19 outbreak caused by the new SARS-CoV-2 coronavirus has become a pandemic, requiring fast and efficient reaction from societies and health care systems all over the world. Fever, coughing and dyspnea are considered the major signs of COVID-19. In addition to the involvement of the respiratory system, the infection may result in other symptoms and signs as well. Based on reports to date, neurological signs or symptoms appear in 30-50% of hospitalized COVID-19 patients, with higher incidence in those with more severe disease. Classical acute neurological syndromes have also been reported to associate with COVID-19. A drop in the volume of services for other acute diseases has been described in countries with healthcare systems focusing on COVID-19. During the COVID-19 epidemic it is also important to provide appropriate continuous care for those with chronic neurological disorders. It will be the task of the future to estimate the collateral damage caused by the COVID-19 epidemic on the outcome of other neurological disorders, and to screen for the possible late neurological complications of the SARS-CoV-2 coronavirus infection.]

Clinical Neuroscience

Matrix metalloproteinases and their tissue inhibitors in relapsing remitting multiple sclerosis: Possible markers and treatment agents

SANLI Arzu, OZTURK Musa, SOYSAL Aysun, DOVENTAS Yasemin, BASOGLU Fulya, GOZUBATIK-CELIK R. Gokcen, BAYBAS Sevim

Matrix metalloproteinases (MMPs), which are synthesized by many cell groups and responsible for the destruction of matrix proteins, and endogen tissue inhibitors of MMPs (TIMPs) have a role in the pathogenesis of Multiple Sclerosis (MS) by affecting the blood-brain barrier. We aimed to investigate the role of MMPs and TIMPs in the immunopathogenesis and in the course of multiple sclerosis (MS). We enrolled 25 relapsing remitting MS patients, who had a definite MS diagnosis according to McDonald criteria and 25 healthy subjects similar for age and gender as control group. MMP-9- and TIMP-1 levels were measured twice in patient group (one time during an attack and one in remission) and once in healthy subjects. MMP-9- and TIMP-levels of patients during attack and remission period and MMP-9/TIMP-1 ratio were found significantly higher than in the control subjects. In patient group MMP-9 and TIMP-1 levels and MMP-9/TIMP-1 ratio during attacks were not significantly different than during remission period. However, when subdivided according to their number of attacks, patients with 2 attacks had significantly higher levels during attack period comparing to remission period (p<0.05); in case of patients with more than 2 attacks did not have a statistically significant difference in attack and remission periods. Matrix metalloproteinases are important actors in MS immunopathogenesis, particularly in the early period and inhibitor agents for these enzymes can be used as a treatment option.

Clinical Neuroscience

[Effective therapy in highly active pediatric multiple sclerosis ]

MERÔ Gabriella, MÓSER Judit, LIPTAI Zoltán, DIÓSZEGHY Péter, BESSENYEI Mónika, CSÉPÁNY Tünde

[Multiple sclerosis (MS) is typically a disease of young adults. Childhood MS can be defined in patients under 18 years of age, although some authors set the limit un­der the age of 16 formerly known as “early-onset multiple sclerosis” or “juvenile multiple sclerosis”, seen in 3-5% of all MS patients. Nowadays, owing to ever-evolving, better diagnostic tools and well-traced, strictly defined diagnostic criteria, childhood MS is showing an increasing incidence worldwide (0.05-2.85/100 000). MS is characterized by recurrent episodes of the central nervous system with demyelination separated in space and time. In childhood almost exclusively the relapsing-remitting (RR) type of MS occurs. Based on experience in adults, the goal in the pediatric population is also the early diagnosis, to initiate adequate DMT as soon as possible and to achieve symptom relief and good quality of life. Based on efficacy and safety studies in the adult population, inter­feron β-1a and glatiramer acetate were first approved by the FDA and EMA for the treatment of childhood MS also. The increased relapse rate and rapid progression of childhood MS and unfavorable therapeutic response to nearly 45% of the first DMT necessitated the testing of more effective and second-line drugs in the population under 18 years of age (PARADIGMS, CONNECT). Although natalizumab was reported to be effective and well-tolerated in highly active RRMS in childhood, evidence based studies were not yet available when our patients’ treatment started. In this article, we report on the successful treatment of three active RRMS patients with individually authorized off-label use of natalizumab.]

Clinical Neuroscience

[Covid-19 associated neurological disorders]

SZÔTS Mónika, PÉTERFI Anna, GERÖLY Júlia, NAGY Ferenc

[The clinical signs of SARS-CoV-2 infection has become more recognisable in recent times. In addition to common symptoms such as fever, cough, dyspnea, pneumonia and ageusia, less common complications can be identified, including many neurological manifestations. In this paper, we discuss three Covid-19 associated neurological disorders (Case 1: Covid-19 encephalitis, Case 2: Covid-19 organic headache, Case 3: SARS-CoV-2-infection and ischaemic stroke). We emphasize in our multiple case study that during the present pandemic, it is especially important for neurologists to be aware of the nervous system complications of the virus infection, thus saving unnecessary examinations and reducing the frequency of patients’ contact with health care personnel. ]